Salvage Therapies After 18F-Fluciclovine Detected Prostate Cancer Recurrences

Background 18 F-Fluciclovine is the most recent prostate cancer (PCa)–directed PET radiotracer approved by the US Food and Drug Administration for detection of recurrent PCa. We report the treatments and outcomes of patients at our institution with PCa recurrences detected on 18 F-fluciclovine PET/CT. Methods We identified men with recurrent PCa detected on 18 F-fluciclovine PET/CT performed between 2017 and 2018 who were previously treated...